Source: Annals of Oncology. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS (TRATAMENTO), GENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANELLI, A. et al. Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancer. Annals of Oncology, v. 14, p. 428-432, 2003Tradução . . Disponível em: https://doi.org/10.1093/annonc/mdg104. Acesso em: 01 jun. 2024.APA
Anelli, A., Brentani, R. R., Gadelha, A. P., Albuquerque, A. A. de, & Soares, F. (2003). Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancer. Annals of Oncology, 14, 428-432. doi:10.1093/annonc/mdg104NLM
Anelli A, Brentani RR, Gadelha AP, Albuquerque AA de, Soares F. Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancer [Internet]. Annals of Oncology. 2003 ; 14 428-432.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/annonc/mdg104Vancouver
Anelli A, Brentani RR, Gadelha AP, Albuquerque AA de, Soares F. Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancer [Internet]. Annals of Oncology. 2003 ; 14 428-432.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/annonc/mdg104
